Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B
Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
To assess efficacy and safety of BeneFix® for prophylaxis in "Short-term" therapy and on
demand therapy for all bleeding episodes of subjects with hemophilia B.